Production, purification and oxidative folding of the mouse recombinant prion protein

A Pavlícek1, L Bednárová, K Holada

  • 1Institute of Microbiology and Immunology, 1st Faculty of Medicine, Charles University, 128 00 Prague, Czechia.

Folia Microbiologica
|December 8, 2007
PubMed

Insights

Researchers developed a method to produce and purify mouse recombinant prion protein (mrPrP) in E. coli. The purified protein

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Protein Chemistry

Background:

  • Prion protein (PrP) misfolding is linked to neurodegenerative diseases.
  • Efficient production of recombinant PrP is crucial for studying its structure and function.
  • Bacterial expression systems offer a scalable platform for protein production.

Purpose of the Study:

  • To establish a method for overexpressing and purifying full-length mouse recombinant prion protein (mrPrP 23-231) in E. coli.
  • To characterize the folding properties of the purified mrPrP.

Main Methods:

  • Overexpression of his-mrPrP fusion protein in E. coli cytoplasm.
  • Purification using affinity chromatography.
  • Solubilization and refolding of purified mrPrP.
  • Analysis of protein conformation using circular dichroism, proteinase K digestion, and sucrose gradient centrifugation.

Main Results:

  • Achieved a typical yield of 8-10 mg of his-mrPrP per liter of bacterial culture.
  • Obtained purified protein with >95% purity.
  • Demonstrated the ability to convert purified mrPrP to a soluble form.
  • Characterized the folding into alpha-helical and beta-sheet conformations and their distinct properties.

Conclusions:

  • A robust method for producing highly pure mouse recombinant prion protein in E. coli was developed.
  • The purified mrPrP can be refolded into different conformations.
  • The study provides a foundation for further investigations into prion protein structure-function relationships and disease mechanisms.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Protein Folding Quality Check in the RER01:29

Protein Folding Quality Check in the RER

ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...
Protein Folding01:25

Protein Folding

Proteins are chains of amino acids linked together by peptide bonds. Upon synthesis, a protein folds into a three-dimensional conformation, critical to its biological function. Interactions between its constituent amino acids guide protein folding, and hence the protein structure is primarily dependent on its amino acid sequence.
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...